Organic–Inorganic Composites for Bone Drug Delivery
Authors:
- 20 October 2009
- journal article
- review article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 10 (4) , 1158-1171
Abstract
This review paper attempts to provide an overview in the fabrication and application of organic–inorganic based composites in the field of local drug delivery for bone. The concept of local drug delivery exists for a few decades. However, local drug delivery in bone and specially application of composites for delivery of drugs to bone is an area for potential research interest in the recent time. The advantages attained by an organic–inorganic composite when compared to its individual components include their ability to release drug, adopting to the natural environment and supporting local area until complete bone regeneration, which make them carriers of interest for local drug delivery for bone.Keywords
This publication has 74 references indexed in Scilit:
- Mechanical properties and apatite-forming ability of PMMA bone cementsMaterials & Design (1980-2015), 2009
- Global burden of trauma: Need for effective fracture therapiesIndian Journal of Orthopaedics, 2009
- Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheresJournal of Controlled Release, 2008
- Elution characteristics and mechanical properties of calcium sulfate-loaded bone cement containing teicoplaninJournal of Orthopaedic Science, 2007
- Fabrication, characterization and long-term in vitro release of hydrophilic drug using PHBV/HA composite microspheresMaterials Letters, 2007
- Controlled release of gentamicin from calcium phosphate—poly(lactic acid-co-glycolic acid) composite bone cementBiomaterials, 2006
- Fabrication and release behavior of a novel freeze-gelled chitosan/γ-PGA scaffold as a carrier for rhBMP-2Dental Materials, 2006
- Osteoporosis and Skeletal FracturesHSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery, 2006
- Efficacy of Ciprofloxacin-Releasing Bioabsorbable Osteoconductive Bone Defect Filler for Treatment of Experimental Osteomyelitis Due toStaphylococcus aureusAntimicrobial Agents and Chemotherapy, 2005
- Antimicrobial prophylaxis in surgeryInfectious Diseases Newsletter, 1991